State Board of Administration of Florida Retirement System Sold 2,290 Shares of PAREXEL International Co. (PRXL)

State Board of Administration of Florida Retirement System Sold 2,290 Shares of PAREXEL International Co. (PRXL)

State Board of Administration of Florida Retirement System decreased its position in PAREXEL International Co. (NASDAQ:PRXL) by 6.1% during the first quarter, Holdings Channel reports. The fund owned 34,993 shares of the medical research company’s stock after selling 2,290 shares during the period. State Board of Administration of Florida Retirement System’s holdings in PAREXEL International were worth $2,208,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Glen Harbor Capital Management LLC raised its position in shares of PAREXEL International by 7.1% in the first quarter. Glen Harbor Capital Management LLC now owns 2,520 shares of the medical research company’s stock worth $159,000 after buying an additional 168 shares in the last quarter. Elkfork Partners LLC purchased a new position in shares of PAREXEL International during the fourth quarter worth approximately $188,000. Sapphire Star Partners LP purchased a new position in shares of PAREXEL International during the fourth quarter worth approximately $230,000. Capstone Asset Management Co. raised its position in shares of PAREXEL International by 3.8% in the first quarter. Capstone Asset Management Co. now owns 4,409 shares of the medical research company’s stock worth $278,000 after buying an additional 160 shares in the last quarter. Finally, Shelton Capital Management purchased a new position in shares of PAREXEL International during the fourth quarter worth approximately $344,000. 91.44% of the stock is currently owned by institutional investors and hedge funds.

Shares of PAREXEL International Co. (NASDAQ PRXL) opened at 82.05 on Friday. PAREXEL International Co. has a 52-week low of $51.16 and a 52-week high of $82.07. The stock’s 50 day moving average price is $71.40 and its 200-day moving average price is $66.12. The company has a market capitalization of $4.17 billion, a P/E ratio of 36.07 and a beta of 0.82.

PAREXEL International (NASDAQ:PRXL) last released its quarterly earnings data on Wednesday, May 3rd. The medical research company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.01. The business had revenue of $529.30 million for the quarter, compared to analysts’ expectations of $529.38 million. PAREXEL International had a return on equity of 29.92% and a net margin of 6.34%. The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.89 EPS. On average, equities analysts expect that PAREXEL International Co. will post $3.23 earnings per share for the current year.

A number of research analysts have commented on PRXL shares. Mizuho upped their price objective on PAREXEL International from $66.00 to $75.00 and gave the company a “buy” rating in a report on Tuesday. Barclays PLC reaffirmed an “overweight” rating and issued a $87.00 price objective on shares of PAREXEL International in a report on Wednesday, May 17th. Evercore ISI raised PAREXEL International from an “in-line” rating to an “outperform” rating and set a $85.00 price objective on the stock in a report on Monday, May 15th. Zacks Investment Research raised PAREXEL International from a “sell” rating to a “hold” rating in a report on Wednesday, April 5th. Finally, Goldman Sachs Group Inc raised PAREXEL International from a “sell” rating to a “neutral” rating and upped their price objective for the company from $63.00 to $77.00 in a report on Tuesday, May 23rd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $71.33.

About PAREXEL International

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:PRXL”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PAREXEL International Co. (NASDAQ:PRXL).

Related posts

Leave a Comment